Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
OGEN	ORAGENICS INC	$2.17M	-144.20%	-112.80%	-279.81%	-1,432.10%	0.50	3.02	N/A	N/A	N/A
HRTX	HERON THERAPEUTICS INC	$58.09M	-300.90%	-13.60%	-16.48%	-9.70%	35.52	2.49	70.10%	-22.50%	-17.46%
HLSQ	TESSERA DEFENSE & HOMELAND SECURITY INC	$1.16M	-1,519.30%	-459.40%	-396.81%	-2,658.80%	0.97	0.24	29.20%	-21,929.80%	-21,520.78%
VALN	VALNEVA SE	$582.22M	-152.10%	-39.20%	-41.05%	-32.90%	3.79	2.16	16.40%	-110.30%	-81.83%
CNTX	CONTEXT THERAPEUTICS INC	$29.31M	-82.10%	-72.70%	-120.15%	1,191.40%	0.21	5.81	N/A	N/A	N/A
IMNN	IMUNON INC	$7.49M	-315.30%	-133.10%	-143.36%	-874.60%	2.58	1.82	N/A	N/A	N/A
QNRX	QUOIN PHARMACEUTICALS LTD	$17.15M	-303.40%	-137.10%	-348.47%	-436.50%	2.04	1.76	N/A	N/A	N/A
INM	INMED PHARMACEUTICALS INC	$7.55M	-178.30%	-141.50%	-1,167.45%	-2,023.00%	1.82	1.37	N/A	N/A	N/A
VIVS	VIVOSIM LABS INC	$3.01M	-612.20%	-177.00%	-630.55%	-1,765.80%	-2.64	1.70	100.00%	-11,016.10%	-11,000.89%
ATOS	ATOSSA THERAPEUTICS INC	$19.86M	-103.00%	-85.80%	-140.55%	3,053.40%	0.20	5.69	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$35.84M	83.40%	23.40%	36.60%	-371.10%	0.33	4.08	100.00%	32.20%	32.23%
NRSN	NEUROSENSE THERAPEUTICS LTD	$7.78M	N/A	-773.60%	469.81%	561.50%	-1.43	0.28	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$603.80M	13.70%	4.50%	-10.40%	160.40%	0.25	0.16	-1,111.40%	2,254.30%	-4,368.57%
IMA	IMAGENEBIO INC	$51.99M	-39.60%	-35.40%	-38.15%	-106.10%	0.07	21.47	N/A	N/A	N/A
LNAI	LUNAI BIOWORKS INC	$8.02M	N/A	-1,617.80%	1,355.58%	749.20%	-2.03	0.19	100.00%	-612,568.10%	-609,894.27%
VRAX	VIRAX BIOLABS GROUP LTD	$1.29M	-75.70%	-68.10%	-76.73%	-333.40%	0.13	9.97	61.90%	-40,439.10%	-47,188.42%
CLRB	CELLECTAR BIOSCIENCES INC	$17.20M	-179.50%	-115.40%	-71.09%	1,353.30%	0.23	6.66	N/A	N/A	N/A
IMRN	IMMURON LTD	$9.60M	-38.70%	-31.90%	-32.25%	-95.50%	0.18	7.26	69.20%	-41.40%	-41.26%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$5.53M	-82.30%	-76.00%	-85.34%	-396.30%	0.07	17.15	100.00%	-44,771.80%	-44,686.72%
LONA	LEONABIO INC	$33.07M	-411.60%	-225.70%	-288.23%	-1,822.40%	0.69	7.01	N/A	N/A	N/A
NCNA	NUCANA PLC	$0.00	-41.80%	-33.60%	-52.21%	2,103.00%	0.27	4.73	N/A	N/A	N/A
NCEL	NEWCELX LTD	$15.99M	-218.10%	-138.70%	-149.26%	1,528.60%	0.61	0.40	N/A	N/A	N/A
PLYX	POLARYX THERAPEUTICS INC	$103.18M	-117.60%	-103.50%	-62.61%	1,235.70%	0.08	13.53	N/A	N/A	N/A
LSTA	LISATA THERAPEUTICS INC	$13.25M	-113.80%	-90.50%	-186.67%	755.30%	0.37	3.69	100.00%	-14,621.00%	-15,008.00%
AZTR	AZITRA INC	$7.94M	-205.40%	-161.70%	-165.92%	-1,068.30%	0.22	4.86	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$1.74M	-88.50%	-61.60%	-57.34%	-4,372.20%	0.31	4.31	N/A	N/A	N/A
MTVA	METAVIA INC	$10.94M	-209.70%	-107.90%	-208.61%	258.70%	0.95	2.06	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$3.35M	-214.20%	-126.70%	-283.01%	-612.50%	1.40	2.08	N/A	N/A	N/A
APRE	APREA THERAPEUTICS INC	$9.70M	-47.60%	-41.00%	-32.43%	515.70%	0.10	13.55	100.00%	-237,362.80%	-245,156.76%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$42.32M	-181.50%	-111.60%	-324.49%	-222.20%	0.90	0.85	N/A	N/A	N/A
PHIO	PHIO PHARMACEUTICALS CORP	$11.97M	-87.40%	-79.80%	-102.40%	1,902.50%	0.14	8.39	N/A	N/A	N/A
CLLS	CELLECTIS SA	$106.87M	-94.20%	-21.30%	-36.47%	-20.90%	5.51	1.37	100.00%	-102.30%	-75.66%
PHAR	PHARMING GROUP NV	$708.49M	3.40%	1.90%	4.23%	6.50%	0.73	3.01	86.50%	2.50%	4.32%
MRKR	MARKER THERAPEUTICS INC	$18.34M	-57.00%	-47.80%	-71.70%	1,454.00%	0.20	6.03	100.00%	-372.70%	-373.34%
MOLN	MOLECULAR PARTNERS AG	$149.39M	-67.60%	-54.20%	-77.03%	-401.30%	0.29	7.27	N/A	N/A	N/A
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$5.47M	-160.30%	-102.00%	-194.70%	-235.30%	0.88	2.27	-147.60%	-3,376.30%	-3,374.04%
MNOV	MEDICINOVA INC	$94.50M	-26.50%	-24.40%	-28.68%	-463.70%	0.09	8.75	37.70%	-1,168.20%	-1,167.55%
MGX	METAGENOMI THERAPEUTICS INC	$42.69M	-63.60%	-44.50%	-64.11%	-50.70%	0.54	4.50	100.00%	-689.20%	-690.60%
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-42.00%	-32.10%	-41.83%	-215.10%	0.32	2.41	N/A	N/A	N/A
ESLA	ESTRELLA IMMUNOPHARMA INC	$20.01M	N/A	-328.80%	134.74%	105.40%	-1.25	0.20	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$5.30M	-40.60%	-35.00%	-40.76%	683.50%	0.15	7.44	100.00%	-75.90%	-75.91%
ALZN	ALZAMEND NEURO INC	$8.78M	-277.90%	-184.20%	-156.66%	1,534.20%	0.47	3.01	N/A	N/A	N/A
MLEC	MOOLEC SCIENCE SA	$3.62M	N/A	N/A	N/A	N/A	5.81	0.15	39.30%	N/A	N/A
ATYR	ATYR PHARMA INC	$30.21M	-95.60%	-69.70%	-104.07%	-83.50%	0.44	5.12	100.00%	-32,003.70%	-32,003.68%
MREO	MEREO BIOPHARMA GROUP PLC	$59.56M	-74.80%	-64.30%	-100.37%	3,309.10%	0.21	5.88	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$12.45M	-58.60%	-55.80%	-40.88%	-138.50%	0.04	14.62	N/A	N/A	N/A
ALLR	ALLARITY THERAPEUTICS INC	$15.35M	-152.80%	-46.50%	-318.72%	474.10%	8.08	1.11	100.00%	-3,575.10%	-3,266.67%
MENS	JYONG BIOTECH LTD	$154.34M	N/A	N/A	15.19%	N/A	-1.83	0.45	N/A	N/A	N/A
BRTX	BIORESTORATIVE THERAPIES INC	$2.97M	-423.80%	-193.30%	-365.43%	-3,005.60%	0.53	2.35	92.10%	-3,089.60%	-3,089.55%
PASG	PASSAGE BIO INC	$14.90M	-218.60%	-72.90%	-810.41%	-1,526.60%	4.65	1.22	N/A	N/A	N/A
NEUP	NEUPHORIA THERAPEUTICS INC	$19.32M	-55.90%	-42.20%	-48.62%	1,079.50%	0.17	27.85	100.00%	-1,145.70%	-1,157.51%
MBIO	MUSTANG BIO INC	$3.64M	-34.20%	-17.50%	-39.42%	38.40%	1.07	1.97	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$7.17M	-204.30%	-141.90%	-91.67%	995.20%	0.21	5.87	N/A	N/A	N/A
JAGX	JAGUAR HEALTH INC	$1.83M	N/A	-131.50%	-401.61%	-277.10%	4.43	0.69	82.30%	-188.50%	-127.26%
LPCN	LIPOCINE INC	$17.81M	-64.70%	-57.60%	-54.44%	-87.60%	0.10	11.48	100.00%	-755.10%	-755.11%
AIM	AIM IMMUNOTECH INC	$5.27M	N/A	-175.10%	-168.68%	4,516.60%	0.64	2.11	-23.20%	-15,021.10%	-13,823.16%
LITS	LITE STRATEGY INC	$41.81M	-97.30%	-95.90%	-170.94%	-109.30%	0.03	5.75	N/A	N/A	N/A
LEXX	LEXARIA BIOSCIENCE CORP	$5.17M	-160.70%	-143.90%	-175.71%	-1,299.10%	0.09	10.60	100.00%	-3,985.60%	-3,983.31%
XTLB	XTL BIOPHARMACEUTICALS LTD	$6.27M	-269.00%	-159.90%	2,740.94%	1,450.40%	-1.65	0.40	N/A	N/A	N/A
GDTC	CYTOMED THERAPEUTICS LTD	$10.52M	-51.30%	-44.10%	-54.42%	-76.20%	0.17	5.17	100.00%	-1,227.10%	-1,220.63%
EOCN	EOCENE LTD	$3.55M	-73.70%	-60.90%	-78.04%	-105.60%	0.44	4.16	N/A	N/A	N/A
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$1.43B	-240.30%	-46.90%	-103.92%	-86.40%	4.81	1.22	93.90%	-228.50%	-217.94%
ADXN	ADDEX THERAPEUTICS LTD	$3.01M	-172.60%	-125.30%	-324.35%	-234.70%	0.82	0.76	100.00%	-8,271.00%	-8,263.75%
IMMP	IMMUTEP LTD	$34.71M	-61.80%	-50.90%	-83.72%	-144.80%	0.49	2.97	100.00%	-777.70%	-777.30%
NTRB	NUTRIBAND INC	$100.28M	-109.00%	-95.50%	-128.89%	-1,502.60%	0.18	4.21	33.10%	-430.40%	-429.14%
KYNB	KYNTRA BIO INC	$27.49M	-605.50%	156.80%	295.95%	218.90%	-3.62	2.69	6.30%	3,967.80%	4,168.98%
ACXP	ACURX PHARMACEUTICALS INC	$6.88M	-124.70%	-87.50%	-92.08%	322.70%	0.35	3.88	N/A	N/A	N/A
XCUR	EXICURE INC	$7.46M	-237.90%	-62.00%	-123.38%	596.60%	10.67	0.56	N/A	N/A	N/A
XLO	XILIO THERAPEUTICS INC	$58.81M	-50.80%	-14.40%	-18.18%	95.50%	1.14	4.25	100.00%	-34.10%	-34.06%
KAPA	KAIROS PHARMA LTD	$39.34M	-98.80%	-93.60%	-138.51%	-333.80%	0.06	11.98	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$16.37M	-49.50%	-46.80%	-42.69%	3,511.60%	0.04	26.25	N/A	N/A	N/A
SILO	SILO PHARMA INC	$2.56M	-81.70%	-66.30%	-90.70%	-248.90%	0.22	5.36	-14.80%	-8,269.50%	-8,195.88%
KPRX	KIORA PHARMACEUTICALS INC	$11.50M	-63.40%	-44.30%	-57.27%	-111.20%	0.41	8.97	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$80.47M	-908.60%	-803.00%	-116.68%	1,108.60%	0.07	16.14	N/A	N/A	N/A
DWTX	DOGWOOD THERAPEUTICS INC	$45.89M	-62.40%	-40.30%	-49.45%	4,898.50%	0.18	3.89	N/A	N/A	N/A
ABVC	ABVC BIOPHARMA INC	$27.72M	-64.30%	-34.90%	-50.71%	-42.50%	0.69	0.07	N/A	N/A	N/A
DYAI	DYADIC INTERNATIONAL INC	$16.98M	-2,918.10%	-84.80%	-270.36%	-141.80%	-3.74	1.65	16.20%	-200.50%	-188.70%
HIND	VYOME HOLDINGS INC	$14.18M	-198.70%	-130.70%	-145.50%	776.80%	0.26	4.37	52.30%	544.10%	538.19%
SEER	SEER INC	$119.05M	-27.20%	-24.00%	-27.67%	-27.00%	0.14	14.74	47.70%	-478.00%	-477.55%
ENVB	ENVERIC BIOSCIENCES INC	$6.49M	-232.70%	-202.10%	-107.99%	4,045.10%	0.11	10.21	N/A	N/A	N/A
TOVX	THERIVA BIOLOGICS INC	$9.64M	-105.60%	-36.90%	-51.08%	-71.60%	1.86	1.13	100.00%	-4,376.00%	-3,872.67%
TRAW	TRAWS PHARMA INC	$9.62M	-22,616.20%	-156.80%	-964.61%	241.70%	5.78	0.93	N/A	N/A	N/A
SER	SERINA THERAPEUTICS INC	$52.83M	-252.50%	-132.70%	-93.21%	-2,452.00%	0.38	6.65	N/A	N/A	N/A
ENLV	ENLIVEX LTD	$8.08M	162.90%	129.60%	85.50%	170.60%	0.26	119.39	N/A	N/A	N/A
ENSC	ENSYSCE BIOSCIENCES INC	$8.11M	-1,532.30%	-320.50%	1,135.00%	1,175.80%	-5.20	0.70	N/A	N/A	N/A
SKYE	SKYE BIOSCIENCE INC	$7.04M	-329.10%	-201.80%	10,151.41%	-912.80%	-23.19	0.95	N/A	N/A	N/A
CELU	CELULARITY INC	$44.46M	N/A	-64.60%	-229.85%	-119.30%	-3.82	0.09	5.30%	-375.90%	-350.14%
REVB	REVELATION BIOSCIENCES INC	$3.24M	-179.00%	-147.80%	-101.25%	2,230.40%	0.24	6.21	N/A	N/A	N/A
SXTP	60 DEGREES PHARMACEUTICALS INC	$4.40M	-224.70%	-149.20%	-302.61%	-614.40%	0.67	2.33	-42.70%	-4,386.60%	-4,125.12%
DRMA	DERMATA THERAPEUTICS INC	$4.55M	-166.70%	-130.10%	N/A	-1,537.30%	0.53	N/A	N/A	N/A	N/A
RADX	RADIOPHARM THERANOSTICS LTD	$16.16M	-158.80%	-75.20%	-133.33%	-208.80%	1.53	1.16	9.50%	-1,992.50%	-1,986.44%
ERNA	ERNEXA THERAPEUTICS INC	$5.16M	-306.30%	-170.10%	-362.58%	1,161.00%	0.97	2.01	N/A	N/A	N/A
SLXN	SILEXION THERAPEUTICS CORP	$1.77M	-563.10%	-201.70%	-5,232.22%	-3,594.70%	95.50	0.94	N/A	N/A	N/A
SNGX	SOLIGENIX INC	$7.94M	-181.00%	-107.90%	-153.89%	447.70%	0.58	2.77	N/A	N/A	N/A
SNTI	SENTI BIOSCIENCES HOLDINGS INC	$9.56M	-1,540.00%	-113.10%	-285.84%	-122.70%	-10.73	0.83	100.00%	-90,116.40%	-90,116.36%
EVAX	EVAXION A	$27.27M	-109.90%	-41.40%	-41.29%	-58.30%	1.03	5.06	100.00%	-115.50%	-89.56%
PULM	PULMATRIX INC	$5.69M	-109.70%	-95.60%	-156.94%	1,482.20%	0.27	4.70	N/A	N/A	N/A
CANF	CAN-FITE BIOPHARMA LTD	$4.67M	N/A	N/A	N/A	N/A	0.66	3.60	N/A	N/A	N/A
INAB	IN8BIO INC	$12.77M	-91.20%	-76.90%	-95.77%	-366.50%	0.18	8.21	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$31.79M	N/A	-30.20%	-1,536.32%	-266.00%	-1.42	0.70	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)

Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.